Journal article
The use of erythropoiesis-stimulating agents in patients with non-myeloid hematological malignancies: a systematic review
Abstract
The effectiveness of erythropoiesis-stimulating agents (ESAs) for the treatment of anemia in patients with non-myeloid hematological malignancies needs to be assessed as the response to their administration is not uniform and their cost is high. We conducted a systematic review (SR) of the literature to identify reports of the effect of ESAs on survival, quality of life (QOL), transfusion requirements, and anemia. The entries to MEDLINE, …
Authors
Shehata N; Walker I; Meyer R; Haynes AE; Imrie K; for the Cancer Care Ontario Hematology Disease Site Group
Journal
Annals of Hematology, Vol. 87, No. 12, pp. 961–973
Publisher
Springer Nature
Publication Date
12 2008
DOI
10.1007/s00277-008-0525-5
ISSN
0939-5555